Medtronic s Omar Ishrak: FDA should embrace the European device approach | MedCity News
Medtronic ( NYSE:MDT ) CEO Omar Ishrak has had an it-is-what-it-is approach to healthcare reform in the United States. But this weekend he told London s Financial Times he believes the United States should embrace the European approach to medical device approvals a process that has been getting devices to market much faster than the U.S. Food and Drug Administration s 510(k) process. The ...